Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,472 | -9,247 | -3,864 | -15,754 | -11,255 |
| Depreciation Amortization | 336 | 234 | 131 | 1,279 | 1,134 |
| Accounts payable and accrued liabilities | -416 | 767 | -468 | 1,002 | -39 |
| Other Working Capital | -2,754 | -1,869 | -3,519 | 993 | -104 |
| Other Operating Activity | 2,897 | 557 | 1,002 | 831 | 1,071 |
| Operating Cash Flow | $-14,409 | $-9,558 | $-6,718 | $-11,649 | $-9,193 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -18 | -7 | -31 | -31 |
| Purchase Of Investment | -11,245 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 64 | 54 | 54 | 0 | 0 |
| Investing Cash Flow | $-11,199 | $36 | $47 | $-31 | $-31 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -923 | -627 | -334 | -1,181 | -850 |
| Common Stock Issued | 41,193 | 37,941 | 41,193 | 13,650 | 13,650 |
| Other Financing Activity | -3,252 | 0 | -2,965 | -355 | -355 |
| Financing Cash Flow | $37,018 | $37,314 | $37,894 | $12,114 | $12,445 |
| Beginning Cash Position | 8,034 | 8,034 | 8,034 | 7,600 | 7,600 |
| End Cash Position | 19,444 | 35,826 | 39,257 | 8,034 | 10,821 |
| Net Cash Flow | $11,410 | $27,792 | $31,223 | $434 | $3,221 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,409 | -9,558 | -6,718 | -11,649 | -9,193 |
| Capital Expenditure | -18 | -18 | -7 | -31 | -31 |
| Free Cash Flow | -14,427 | -9,576 | -6,725 | -11,680 | -9,224 |